首頁 > 市場調查報告書 > 材料/化學品

市場調查報告書

商品編碼

1983143

糖生物學市場：按產品類型、應用、最終用戶和地區分類

Glycobiology Market, By Product Type, By Application, By End User, By Geography

出版日期: 2026年02月19日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

糖生物學市場預計在 2026 年達到 22 億美元，預計到 2033 年將達到 74.8 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 19.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	22億美元
目標期限：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	19.10%	2033年市場規模預測：	74.8億美元

醣生物學是研究聚醣和糖基化生物分子（統稱為糖分子，包括醣脂、糖蛋白和糖化小分子）的科學分支。聚醣普遍存在於生命體的各個面向。碳水化合物結構與脂質、蛋白質、代謝物和核酸等生物分子的結合，會對其理化性質、細胞內分佈形態、免疫抗原性以及藥物動力學和動態產生顯著影響。

所有細胞以及許多蛋白質（例如糖蛋白）表面都覆蓋著密集而複雜的共用連接的糖鏈序列（稱為寡糖或聚醣）。這些聚醣的生物學功能在複雜的細胞器和生物體的形成中特別重要，這些細胞器和生物體需要細胞間以及與周圍細胞外基質的相互作用。大多數類型的聚醣存在於細胞表面或分泌的大分子中。此外，在細胞核和細胞質中也存在大量代謝迅速的簡單蛋白質結合聚醣，它們在那裡發揮調節開關的作用。

聚醣是一種種類繁多且結構複雜的分子，其功能取決於其獨特的結構。闡明聚醣結構需要有效的酶學工具和分析技術，這些工具和技術與特定的功能相關。聚醣修飾決定了蛋白質和細胞的黏附特性。免疫系統主要透過聚醣與蛋白質的相互作用發揮作用，凸顯了聚醣在生理、病原體識別、癌症和自體免疫疾病中的重要性。

市場動態

糖生物學市場成長的關鍵促進因素包括非內部成長策略的採用，例如市場主要企業的收購。例如，2018年6月，美國生命科學公司安捷倫科技收購了ProZyme Inc.，後者是私人公司。此次收購將使安捷倫科技能夠擴展其糖生物學產品組合。

本次調查的主要特點

本報告對全球糖生物學市場進行了詳細分析，以 2021 年為基準年，給出了預測期（2022-2030 年）的市場規模和複合年成長率。
此外，它還指出了每個細分市場的潛在商機，並說明了該市場中一個有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
本報告根據以下參數對全球糖生物學市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球糖生物學市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

Tracxn Technologies Limited
Agilent Tecnologies, Inc
Blirt.eu
Takara Bio Inc.
Bio-Techne
Bruker Corporation
Thermo Fisher Scientific Inc
Shimadzu Corporation
New England Biolabs.
Waters.co.
Merck KGaA
Palleon Pharmaceuticals
Asparia Glycomics
RayBiotech Life, Inc
Z Biotech, LLC
Chemily Glycoscience
Lectenz Bio,
2BScientific
Glycodiag

第9章分析師建議

機會
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI3639

Glycobiology Market is estimated to be valued at USD 2.2 Bn in 2026 and is expected to reach USD 7.48 Bn by 2033, growing at a compound annual growth rate (CAGR) of 19.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.2 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	19.10%	2033 Value Projection:	USD 7.48 Bn

Glycobiology is the branch of science which deals with the study of Glycan and glycan-modified biomolecules such as glycolipids, glycoproteins and glycosylated small molecules collectively referred to as sugar molecules. Glycan are universal in all aspects of life. The binding of carbohydrate structures to biomolecules, including lipids, proteins, metabolites, and nucleic acids, can profoundly affect their physicochemical properties, subcellular localization, immunogenicity, and pharmacokinetics and pharmacodynamics.

All cells and many proteins such as glycoproteins are covered with dense and complex arrays of covalently linked sugar chains (called oligosaccharides or glycan). The biological roles of these glycan are of particular importance in the assembly of complex multicellular organs and organisms, processes that require interactions between cells and with the surrounding extracellular matrix. Most classes of glycan are found on the surface of cells and secreted macromolecules. In addition, simple, rapidly metabolizing protein-bound glycan are abundant in the nucleus and cytoplasm, where they function as regulatory switches.

Glycan are diverse and complex molecules whose functions are determined by their unique structures. Glycan structures requires effective enzymatic tools and analytical techniques and can be associated with specific functions. Glycosylation defines the adhesive properties of proteins and cells. The immune system functions primarily through carbohydrate-protein interactions, highlighting the importance of carbohydrates in physiology, pathogen recognition, cancer, and autoimmune diseases.

Market Dynamics

Major factors driving growth of the glycobiology market include adoption of inorganic growth strategies such as acquisitions by key players in the market. For instance, in June, 2018, Agilent Technologies, an American life science company, has acquired privately held ProZyme Inc., a provider of glycan analysis, reagents and kits. This acquisition will help the company expand its glycobiology product portfolio

Key features of the study

This report provides in-depth analysis of the global glycobiology market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global glycobiology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Tracxn Technologies Limited, Agilent Tecnologies,Inc., Blirt.eu, Takara Bio Inc., Bio-Techne, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, New England Biolabs., Waters.co., Merck KGaA, Palleon Pharmaceuticals, Asparia Glycomics, RayBiotech Life, Inc., Z Biotech, LLC., Chemily Glycoscience, Lectenz Bio, 2BScientific , and Glycodiag
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global glycobiology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycobiology market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2026 - 2033)
- Instruments
- Enzymes
- Glycosidase
- Heparinase
- Chitinase
- Acetylgalactosaminidase
- PNGase
- Chitobiase
- Others (Hyaluronidase , Hexosaminidase)
- GlcNAc Transferases
- Acetylglucosaminyltransferase
- Exostosin
- Others (GD2 Synthase,B3GANLT)
- GalNAc Transferases
- Polypeptide GalNAc Transferase
- GANLTL
- Others
- Fucosyl Transferases
- Galactosyl Transferases
- Carbohydrate Kinases
- Others
- Consumables
- Reagents & Kits
Application Insights (Revenue, USD Bn, 2026 - 2033)
- Diagnostic Application
- Industrial Application
- Therapeutic Application
- Drug Discovery and Development
- Others
End User Insights (Revenue, USD Bn, 2026 - 2033)
- Research Laboratories
- Hospitals
- Diagnostic Centres
- Biopharmaceutical Companies
- Others
- Food
Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Key Players Insights
- Tracxn Technologies Limited
- Agilent Tecnologies, Inc
- Blirt.eu
- Takara Bio Inc.
- Bio-Techne
- Bruker Corporation
- Thermo Fisher Scientific Inc
- Shimadzu Corporation
- New England Biolabs.
- Waters.co.
- Merck KGaA
- Palleon Pharmaceuticals
- Asparia Glycomics
- RayBiotech Life, Inc
- Z Biotech, LLC
- Chemily Glycoscience
- Lectenz Bio,
- 2BScientific
- Glycodiag

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Global Glycobiology Market, By Product Type
- Global Glycobiology Market, By Application
- Global Glycobiology Market, By End User
- Global Glycobiology Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend

4. Global Glycobiology Market, By Product Type, 2020-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
- Segment Trends
Glycosidase
- Heparinase
- Chitinase
- Acetylgalactosaminidase
- PNGase
- Chitobiase
- Others
GlcNAc Transferases
- Acetylglucosaminyltransferase
- Exostosin
- Others
GalNAc Transferases
- Polypeptide GalNAc Transferase
- GANLTL
- Others
  - Fucosyl Transferases
  - Galactosyl Transferases
  - Carbohydrate Kinases
  - Others
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

5. Global Glycobiology Market, By Application, 2020-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Diagnostic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Industrial Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Therapeutic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

6. Global Glycobiology Market, By End User, 2020-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Diagnostic Centres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Food
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

7. Global Glycobiology Market, By Region, 2020 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Tracxn Technologies Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Tecnologies, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Blirt.eu
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Techne
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bruker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Shimadzu Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
New England Biolabs.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Waters.co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Palleon Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Asparia Glycomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
RayBiotech Life, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Z Biotech, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Chemily Glycoscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lectenz Bio,
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
2BScientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Glycodiag
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies